BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7584668)

  • 1. Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].
    Hu CJ; Ozes ON; Klein SB; Blatt LM; Taylor MW
    J Interferon Cytokine Res; 1995 Mar; 15(3):231-4. PubMed ID: 7584668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
    Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
    J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist.
    Huang Y; Blatt LM; Taylor MW
    J Interferon Cytokine Res; 1995 Apr; 15(4):317-21. PubMed ID: 7627806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
    Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus interferon induces peak mRNA accumulation at lower concentrations than interferon-alpha 2a.
    Klein SB; Blatt LM; Taylor MW
    J Interferon Res; 1993 Oct; 13(5):341-7. PubMed ID: 8301154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor.
    da Silva AJ; Brickelmaier M; Majeau GR; Lukashin AV; Peyman J; Whitty A; Hochman PS
    J Interferon Cytokine Res; 2002 Feb; 22(2):173-88. PubMed ID: 11911800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, Prokaryotic Soluble Expression, and Analysis of Antiviral Activity of Two Novel Feline IFN-ω Proteins.
    Wang X; Li F; Han M; Jia S; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu YG
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32204464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro inhibition of SARS virus replication by human interferons.
    Dahl H; Linde A; Strannegård O
    Scand J Infect Dis; 2004; 36(11-12):829-31. PubMed ID: 15764169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
    Subramanian GM; Moore PA; Gowen BB; Olsen AL; Barnard DL; Paragas J; Hogan RJ; Sidwell RW
    Chemotherapy; 2008; 54(3):176-80. PubMed ID: 18560223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency.
    Foster GR; Rodrigues O; Ghouze F; Schulte-Frohlinde E; Testa D; Liao MJ; Stark GR; Leadbeater L; Thomas HC
    J Interferon Cytokine Res; 1996 Dec; 16(12):1027-33. PubMed ID: 8974005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-species antiviral and antiproliferative activity of human interferon-omega.
    Kubes M; Fuchsberger N; Kontsek P
    J Interferon Res; 1994 Apr; 14(2):57-9. PubMed ID: 8077766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell and virus sensitivity studies with recombinant human alpha interferons.
    Kramer MJ; Dennin R; Kramer C; Jones G; Connell E; Rolon N; Gruarin A; Kale R; Trown PW
    J Interferon Res; 1983; 3(4):425-35. PubMed ID: 6323591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1.
    Siebeck N; Hurley DJ; Garcia M; Greene CE; Köstlin RG; Moore PA; Dietrich UM
    Am J Vet Res; 2006 Aug; 67(8):1406-11. PubMed ID: 16881854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant human consensus interferon-α variant in monkeys, rats and guinea pigs.
    Cai Y; Zhang Z; Fan K; Zhang J; Shen W; Li M; Si D; Luo H; Zeng Y; Fu P; Liu C
    Regul Pept; 2012 Jan; 173(1-3):74-81. PubMed ID: 21985916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somnogenic effects of rabbit and recombinant human interferons in rabbits.
    Kimura M; Majde JA; Toth LA; Opp MR; Krueger JM
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R53-61. PubMed ID: 7519411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons.
    Brod SA; Scott M; Burns DK; Phillips JT
    J Interferon Cytokine Res; 1995 Feb; 15(2):115-22. PubMed ID: 8590314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety pharmacology, toxicology and pharmacokinetic assessment of recombinant human omega-interferon produced from CHO-SS cells.
    Buckwold VE; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):62-70. PubMed ID: 16867173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of an antiviral activity of recombinant consensus interferon with recombinant interferon-alpha-2b.
    Koyama AH; Arakawa T; Adachi A
    Microbes Infect; 1999 Nov; 1(13):1073-7. PubMed ID: 10572309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA; Lingwood CA
    J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of antiviral activity between FeIFN-omega and FeIFN-alpha].
    Wang H; Jia X; Yang L; Sun L; Wang H; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1556-60. PubMed ID: 19160837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.